Mount Yale Investment Advisors LLC Sells 87,663 Shares of CVS Health Co. (NYSE:CVS)

Mount Yale Investment Advisors LLC cut its holdings in shares of CVS Health Co. (NYSE:CVS) by 93.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,915 shares of the pharmacy operator’s stock after selling 87,663 shares during the period. Mount Yale Investment Advisors LLC’s holdings in CVS Health were worth $266,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Farmers National Bank raised its position in CVS Health by 5.9% in the second quarter. Farmers National Bank now owns 97,817 shares of the pharmacy operator’s stock worth $5,777,000 after acquiring an additional 5,453 shares during the period. Strategic Investment Solutions Inc. IL purchased a new position in CVS Health in the 2nd quarter worth approximately $63,000. Brown Financial Advisors purchased a new stake in CVS Health in the 2nd quarter worth $684,000. Sanctuary Advisors LLC bought a new position in CVS Health during the second quarter valued at approximately $8,005,000. Finally, Prio Wealth Limited Partnership grew its holdings in shares of CVS Health by 1.1% in the second quarter. Prio Wealth Limited Partnership now owns 57,413 shares of the pharmacy operator’s stock valued at $3,391,000 after purchasing an additional 600 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Price Performance

Shares of CVS Health stock opened at $57.00 on Thursday. The firm has a market cap of $71.73 billion, a PE ratio of 14.47, a P/E/G ratio of 0.80 and a beta of 0.59. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The business has a 50-day moving average price of $51.27 and a 200 day moving average price of $56.18. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the previous year, the business earned $2.21 earnings per share. Sell-side analysts predict that CVS Health Co. will post 5.22 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.67%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s payout ratio is presently 67.51%.

Wall Street Analysts Forecast Growth

CVS has been the topic of several analyst reports. Truist Financial cut their target price on CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $60.00 to $66.00 in a research report on Monday, November 18th. Royal Bank of Canada dropped their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. Mizuho reduced their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Finally, Barclays decreased their price target on CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research note on Thursday, November 7th. One analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $68.12.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.